Genomic Vision propose des solutions fondées sur
l’analyse structurale de l’ADN et des tests génétiques
dans les domaines du cancer, des maladies héréditaires
rares et de la pharmaco-génomique.


Jonathan Hanley

PhD, MBA, Director of Corporate Strategy USA

With over 20 years of international professional experience in biotechnologies and venture capital investment, Jonathan joined Genomic Vision as head of R&D alliance management.

He began his career in 1993 as a researcher at the CEA-Saclay Research Centre, before joining the private sector five years later, first at Transgenomic Inc., as a product scientist, and then in 2000 at GenOdyssee, as director of functional proteomics. In 2002, he joined the National Physical Laboratories (NPL-Serco) in London, as the Head of Biotechnology, leading a research team and formulating the DTI funded National Measurement for Biotechnology program.

In 2005, his thorough understanding of the biotechnology landscape and his managerial and financial training led his career toward the Amundi venture-capital fund (formerly Société Générale Asset Management), as an analyst and investment manager specialising in biotechnologies.

He has a degree in Biology from the University of Portsmouth and also a doctorate in Biophysics from University College London, as well as an MBA from the Ecole Nationale des Ponts et Chaussées in Paris.